Financials
Financial year 2025
Dison Pharma from Dison, company number BE0640801992, closed financial year 2025 with a result of € 76,391 after tax. For that financial year Dison Pharma recorded a gross margin of € 270,491 and equity of € 301,711. Compared with financial year 2024, the result moved from € 71,903 to € 76,391. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.
€ 301,711
▲ 31% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 76,391
▲ 6% vs 2024
Profit after tax over the fiscal year.
€ 248,721
▲ 26% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 283,111.
People and assets in 2025
2.3
▲ 0.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 118,137
▼ 5% vs 2024
€ 51,400 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 3,986
▼ 19% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 153,532
▼ 21% vs 2024
€ 14,069 is repaid this year. At this pace the long-term loan is gone in ≈ 11 years.
€ 43,905
▼ 31% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 36,413
▲ 1% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 232,456 | € 234,463 | € 266,969 | € 270,491 | ▲ 1% |
| Profit after taxes | € 71,253 | € 73,088 | € 71,903 | € 76,391 | ▲ 6% |
| Equity | € 143,980 | € 179,847 | € 230,732 | € 301,711 | ▲ 31% |
| Total debts | € 528,308 | € 412,955 | € 398,522 | € 336,786 | ▼ 15% |
| Cash | € 232,158 | € 155,784 | € 196,892 | € 248,721 | ▲ 26% |
| Land & buildings | € 197,987 | € 190,731 | € 183,474 | € 176,217 | ▼ 4% |
| Retained profit | € 125,380 | € 161,247 | € 212,132 | € 283,111 | ▲ 33% |
| Dividend | € 27,000 | € 35,000 | € 19,000 | € 0 | ▼ 100% |
| Bank debt | € 282,671 | € 239,064 | € 195,175 | € 153,532 | ▼ 21% |
| Balance sheet total | € 672,289 | € 592,803 | € 629,255 | € 638,498 | ▲ 1% |
| Employees (FTE) | 1.7 | 1.5 | 2.1 | 2.3 | ▲ 0.2 |
Key figures of Dison Pharma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dison Pharma?
What happened at Dison Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 76,391 (▲ 6% vs 2024). Source: NBB ↗
- New establishment in Dison. KBO
- Start of the company according to the CBE. KBO
- Olivier RYCKEBUSCH became a director. NBB
In short
From € 71,253 profit in 2022 to € 76,391 profit in 2025.
Paid € 109,984 in corporate taxes since 2022.
Best year ever: 2025, with € 76,391 profit.
On average € 117,600 of value added per employee in 2025.
Management
Behind Dison Pharma is Olivier RYCKEBUSCH.
Directors
According to the 2025 annual accounts
Olivier RYCKEBUSCH
Director
since 2015
Establishments
Establishment units
Physical locations of this company
Rue Léopold 58
4820 Dison
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0640.801.992
- VAT number
- BE 0640.801.992
- Registered office
- Rue Léopold 58, 4820 Dison
- Names & denominations
- Dison Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 October 2015
- Peppol
- Active · Active since 5 Nov 2025
- Contact
- 087312235
- Activities · NACE
Detailhandel in farmaceutische producten